{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:45:23Z","timestamp":1786985123678,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Defense Medical Bureau","award":["MAB-102-39"],"award-info":[{"award-number":["MAB-102-39"]}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"crossref","award":["TSGH-C103-005-007-009-S05"],"award-info":[{"award-number":["TSGH-C103-005-007-009-S05"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biocel.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T14:59:31Z","timestamp":1507820371000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines"],"prefix":"10.1016","volume":"92","author":[{"given":"Yung-Lung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dueng-Yuan","family":"Hueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2017.10.003_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2017.10.003_bib0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/mol.105.014167","article-title":"Rational development of histone deacetylase inhibitors as anticancer agents: a review","volume":"68","author":"Acharya","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2402535","article-title":"Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)","volume":"16","author":"Almenara","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2017.10.003_bib0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/emboj\/18.5.1223","article-title":"Apoptosis inhibitory activity of cytoplasmic p21(Cip1\/WAF1) in monocytic differentiation","volume":"18","author":"Asada","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.biocel.2017.10.003_bib0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.cellsig.2007.01.017","article-title":"BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS\/ERK","volume":"19","author":"Beck","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.biocel.2017.10.003_bib0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biocel.2017.10.003_bib0035","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2017.10.003_bib0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/cdd.2013.1","article-title":"Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis","volume":"20","author":"Chen","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biocel.2017.10.003_bib0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3727\/096504007783338340","article-title":"Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines","volume":"16","author":"Ciusani","year":"2007","journal-title":"Oncol. Res."},{"key":"10.1016\/j.biocel.2017.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","article-title":"Histone deacetylases, transcriptional control, and cancer","volume":"184","author":"Cress","year":"2000","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Das","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2017.10.003_bib0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.2005.03098.x","article-title":"Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo","volume":"93","author":"Eyupoglu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2017.10.003_bib0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2017.10.003_bib0075","first-page":"2585","article-title":"Temozolomide and treatment of malignant glioma","volume":"6","author":"Friedman","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2017.10.003_bib0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc1319","article-title":"MGMT: its role in cancer aetiology and cancer therapeutics","volume":"4","author":"Gerson","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2017.10.003_bib0085","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.biocel.2017.10.003_bib0090","first-page":"2281","article-title":"Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor","volume":"10","author":"Goubin","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2017.10.003_bib0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2004.11.049","article-title":"Regulation of p21(WAF1\/CIP1) stability by WISp39, a Hsp90 binding TPR protein","volume":"17","author":"Jascur","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biocel.2017.10.003_bib0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/excr.1999.4644","article-title":"p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells","volume":"253","author":"Kang","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biocel.2017.10.003_bib0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0959-437X(00)00174-X","article-title":"Functional significance of histone deacetylase diversity","volume":"11","author":"Khochbin","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.biocel.2017.10.003_bib0110","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2017.10.003_bib0115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415","article-title":"Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis","volume":"84","author":"Koopman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2017.10.003_bib0120","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1172\/JCI41939","article-title":"Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer","volume":"120","author":"Koster","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2017.10.003_bib0125","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/0008-5472.CAN-07-5807","article-title":"Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1\/2","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2017.10.003_bib0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.1.110304.100043","article-title":"Molecular pathology of malignant gliomas","volume":"1","author":"Louis","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF03402044","article-title":"Histone acetylation modifiers in the pathogenesis of malignant disease","volume":"6","author":"Mahlknecht","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.biocel.2017.10.003_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2017.10.003_bib0145","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biocel.2017.10.003_bib0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0155","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1021\/jm0303094","article-title":"Histone deacetylase inhibitors","volume":"46","author":"Miller","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biocel.2017.10.003_bib0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.biocel.2017.10.003_bib0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","article-title":"Inhibitors of mammalian G1 cyclin-dependent kinases","volume":"9","author":"Sherr","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.biocel.2017.10.003_bib0170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2017.10.003_bib0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nsmb.2581","article-title":"Scratching the (lateral) surface of chromatin regulation by histone modifications","volume":"20","author":"Tropberger","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biocel.2017.10.003_bib0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-409X(98)00084-2","article-title":"Carrier-mediated or specialized transport of drugs across the blood-brain barrier","volume":"36","author":"Tsuji","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biocel.2017.10.003_bib0185","first-page":"549","article-title":"Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis","volume":"103","author":"Wetzel","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.biocel.2017.10.003_bib0190","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1227\/01.NEU.0000360130.52812.1D","article-title":"Effect of simvastatin on glioma cell proliferation, migration, and apoptosis","volume":"65","author":"Wu","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biocel.2017.10.003_bib0195","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2017.10.003_bib0200","doi-asserted-by":"crossref","first-page":"15540","DOI":"10.1073\/pnas.0607518103","article-title":"Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor","volume":"103","author":"Xu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272517302613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272517302613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:10:16Z","timestamp":1761203416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272517302613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"alternative-id":["S1357272517302613"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2017.10.003","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}